Urenco Chairman Knighted in 2014 Queen’s Birthday Honours
16 June 2014 Global NewsThe Urenco Board is delighted to announce that Chairman, Dr John Hood, has received a Knighthood in the 2014 Queen's Birthday Honours list.
Dr Hood has been made a Knights Companion with the title Sir John Hood KNZM for his services to tertiary education.
Helmut Engelbrecht, CEO, Urenco, comments:
“John has made an outstanding contribution to education both in New Zealand and in the UK. On behalf of the Urenco Group, I congratulate him on the honour bestowed.”
More global stories
Urenco signs new customer in Europe as part of diversified supply
Global 28 July 2025Urenco has signed a new agreement to supply enrichment services to nuclear power plants in Slovakia for the first time.
Read moreUrenco has signed a new agreement to supply enrichment services to nuclear power plants in Slovakia for the first time.
Read moreInspiring women at WiN 2025
Global 22 July 2025Colleagues from across our sites represented Urenco at the annual Women in Nuclear (WiN) global conference in London last week.
Read moreColleagues from across our sites represented Urenco at the annual Women in Nuclear (WiN) global conference in London last week.
Read moreAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries